Clinical Trans Valid: The Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Diseases

美国医疗保健正在迅速演变为一种医疗保健的效率和质量 共同主导的驱动因素。护理点技术(POCT)是医疗服务提供者和 患者可以立即收到关于关键健康问题的反馈。在急诊护理环境中，照顾者 需要实时POCT来指导在快速变化的情况下的治疗；以及在门诊 环境提供者正在想方设法让患者参与预防措施并实施 精准医学。CAPCaT的目标是开发和优化新型POCT，以提高 心、肺、血和睡眠(HLBS)疾病的诊断和治疗。《临床》 翻译和验证(CTV)核心将负责验证原型和 确定在适合特定环境的环境中采用这些设备的可行性 正在测试的技术。因此，我们将维持一系列必要的服务，以 促进临床研究，并支持个别项目的特定需求。

American healthcare is rapidly evolving to a state where efficiency and quality in health care are co-dominant drivers. Point-of-care technologies (POCT) are an important tool for providers and patients to receive immediate feedback on critical health issues. In acute care settings, caregivers need real-time POCT to guide treatment in rapidly changing circumstances; and in the outpatient setting providers are seeking ways to engage patients with preventative measures and implement precision medicine. The goal of CAPCaT is to develop and optimize novel POCT to improve the diagnosis and management of heart, lung, blood and sleep (HLBS) diseases. The Clinical Translation and Validation (CTV) core will be responsible for validating the prototypes and establishing the feasibility of adoption of these devices in settings appropriate to the specific technology being tested. Therefore, we will maintain a broad array of services necessary to facilitate clinical research, and support the specific needs of individual projects.